Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo
Authors
Keywords
-
Journal
Virulence
Volume 8, Issue 6, Pages 859-874
Publisher
Informa UK Limited
Online
2016-12-19
DOI
10.1080/21505594.2016.1270494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies
- (2015) Eun Hwa Choi et al. Clinical and Vaccine Immunology
- The incidence of Staphylococcus aureus ST8-USA300 among French pediatric inpatients is rising
- (2015) N. van der Mee-Marquet et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the cap5 Locus
- (2015) Susan Boyle-Vavra et al. mBio
- Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial
- (2015) Jack Levy et al. Human Vaccines & Immunotherapeutics
- Efficacy profile of a bivalent Staphylococcus aureusglycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
- (2015) Ali Fattom et al. Human Vaccines & Immunotherapeutics
- Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model
- (2014) Jamese J. Hilliard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Where does a Staphylococcus aureus vaccine stand?
- (2014) V.G. Fowler et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibodies to Staphylococcus aureus Serotype 8 Capsular Polysaccharide React with and Protect against Serotype 5 and 8 Isolates
- (2014) Saeyoung Park et al. INFECTION AND IMMUNITY
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A
- (2014) Christopher P. Montgomery et al. INFECTION AND IMMUNITY
- Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study
- (2014) Daniel J. Diekema et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Analysis of the Staphylococcus aureus capsule biosynthesis pathway in vitro: Characterization of the UDP-GlcNAc C6 dehydratases CapD and CapE and identification of enzyme inhibitors
- (2014) Wenjin Li et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins ofStaphylococcus aureuswith a single human monoclonal antibody
- (2014) Harald Rouha et al. mAbs
- Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection
- (2014) Michael R. Yeaman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Origin and Evolution of European Community-Acquired Methicillin-Resistant Staphylococcus aureus
- (2014) M. Stegger et al. mBio
- Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
- (2014) Ingrid L. Scully et al. Frontiers in Immunology
- Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia
- (2013) L. Hua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus
- (2013) Anne-Catrin Uhlemann et al. INFECTION GENETICS AND EVOLUTION
- Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
- (2013) Michael Wacker et al. JOURNAL OF INFECTIOUS DISEASES
- Capsular polysaccharides are an important immune evasion mechanism forStaphylococcus aureus
- (2013) Jasdeep S. Nanra et al. Human Vaccines & Immunotherapeutics
- Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency
- (2012) C. Tkaczyk et al. Clinical and Vaccine Immunology
- USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus
- (2012) G.R. Nimmo CLINICAL MICROBIOLOGY AND INFECTION
- Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
- (2012) J. P. Murad et al. CURRENT MOLECULAR MEDICINE
- Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice
- (2012) Hwan Keun Kim et al. INFECTION AND IMMUNITY
- Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model
- (2012) Amita Joshi et al. Human Vaccines & Immunotherapeutics
- Immunosuppressive monoclonal antibodies: current and next generation
- (2011) D. Focosi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Viral infections associated with the clinical use of monoclonal antibodies
- (2011) G. Gentile et al. CLINICAL MICROBIOLOGY AND INFECTION
- Novel targeted immunotherapy approaches for staphylococcal infection
- (2010) Michael Otto EXPERT OPINION ON BIOLOGICAL THERAPY
- Staphylococcus aureuscapsule type 8 antibodies provide inconsistent efficacy in murine Models of staphylococcal infection
- (2010) James Cook et al. Human vaccines & immunotherapeutics
- Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice
- (2010) David Skurnik et al. JOURNAL OF CLINICAL INVESTIGATION
- Staphylococcal Vaccines and Immunotherapies
- (2009) Adam C. Schaffer et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
- (2009) M. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice
- (2008) L. P. N. Tuchscherr et al. INFECTION AND IMMUNITY
- Comparison of Virulence in Community‐Associated Methicillin‐ResistantStaphylococcus aureusPulsotypes USA300 and USA400 in a Rat Model of Pneumonia
- (2008) Christopher P. Montgomery et al. JOURNAL OF INFECTIOUS DISEASES
- Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
- (2008) Caroline L. Trotter et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search